Article
Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
1 Jan 2014
Abstract excerpt
Iodide uptake across the membranes of thyroid follicular cells and cancer cells occurs through an active transport process mediated by the sodium-iodide symporter (NIS). The rat and human NIS-coding genes were cloned and identified in 1996. Evaluation of NIS gene and protein expression is critical for the management of thyroid cancer, and several approaches to increase NIS levels have been tried. Identification...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
